default author photo

Robert Janssen

Dynavax Technologies Corporation

Emeryville, CA 94608

United States

  • Dynavax Technologies Corporation

SCHOLARLY PAPERS

1

DOWNLOADS

456

TOTAL CITATIONS

1

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Safety and Immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC-COV1901) Adjuvanted With CpG 1018 and Aluminum Hydroxide in Healthy Adults: A Phase 1, Dose-Escalation Study

Number of pages: 22 Posted: 15 Apr 2021
Szu-Min Hsieh, Wang-Da Liu, Yu-Shan Huang, Yi‑Jiun Lin, Erh-Fang Hsieh, Wei-Cheng Lian, Charles Chen, Robert Janssen, I-Chen Tai and Shan-Chwen Chang
National Taiwan University - Section of Infectious Diseases, National Taiwan University - Section of Infectious Diseases, National Taiwan University - Section of Infectious Diseases, Medigen Vaccine Biologics Corp., Medigen Vaccine Biologics Corp., Medigen Vaccine Biologics Corp., Medigen Vaccine Biologics Corp., Dynavax Technologies Corporation, Medigen Vaccine Biologics Corp. and National Taiwan University - Section of Infectious Diseases
Downloads 456 (157,424)
Citation 1

Abstract:

Loading...

COVID-19 vaccine; CpG 1018; S-2P protein